Allurion Technologies, INC S-1 registration statements

Allurion Technologies is seeking to raise capital through an offering of common stock, pre-funded warrants, and common stock purchase warrants.

Allurion Technologies plans to raise capital through an offering of common stock, pre-funded warrants, and common warrants.

Allurion Technologies, a medical device company focused on weight loss solutions, has filed a registration statement for a potential offering of up to $30 million in common stock, pre-funded warrants, and common warrants.

Allurion Technologies files an amendment to its S-1 registration statement to register the sale of up to 65,211,325 shares of common stock by a selling securityholder.

Allurion Technologies has filed an amendment to its S-1 registration statement, covering the potential resale of up to 65,211,325 shares of common stock by a selling securityholder.

Allurion Technologies announces a public offering of up to $20 million of common stock and warrants to fund clinical trials, commercial sales, and research and development.

Allurion Technologies has filed an S-1 registration statement for the potential resale of up to 30,191,900 shares of common stock upon conversion of convertible notes held by a selling securityholder.